CLINICAL_TRIALS
trial_result
· 2020-02-13
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis [Phase 2]
Summary
Phase 2 trial update for JKB-122 in nonalcoholic steatohepatitis with fibrosis to evaluate efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TaiwanJ Pharmaceuticals Co., Ltd | Conditions: Nonalcoholic Steatohepatitis (NASH) With Fibrosis | Phase 2 | Status: UNKNOWN